cm4620
Small moleculeexperimental
Clinical trial activity
5 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
0
Phase 4
0
Earliest trial started Mar 12, 2018 (NCT03401190)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04661540 | Phase 2 | Dec 31, 2020 | CalciMedica, Inc., Northwestern University |
| NCT04345614 | Phase 2 | Apr 8, 2020 | CalciMedica, Inc. |
| NCT04195347 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2019 | CalciMedica, Inc., St. Jude Children's Hospital |
| NCT03709342 | Phase 2 | Jan 6, 2019 | CalciMedica, Inc. |
| NCT03401190 | Phase 2 | Mar 12, 2018 | CalciMedica, Inc., University of California, San Francisco |
Showing 5 of 5 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CalciMedica, Inc. | For profit | 5 | 4 | 1 | 2018 |
| Northwestern University | Academic/Hospital | 1 | 0 | 1 | 2020 |
| St. Jude Children's Hospital | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of California, San Francisco | Academic/Hospital | 1 | 0 | 1 | 2018 |
4 organizations
Page 1 / 1